#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neutropenia Glomerulonephritis membranous HER2 mutant non-small cell lung cancer Cervix carcinoma Osteosarcoma recurrent Polymyositis Ehlers-Danlos syndrome Subdural haematoma Cataract Hypomagnesaemia Narcolepsy Pyoderma gangrenosum Medulloblastoma recurrent Cutaneous T-cell lymphoma stage II Hereditary hypophosphataemic rickets More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Basic Information Kearns-Sayre syndrome – Treatment Friedreich’s ataxia – Treatment Rhabdomyosarcoma – Basic Information Leiomyosarcoma metastatic – Trials in Disease Wolfram syndrome – Diagnostics Haemophilia A without inhibitors – Life with Disease Hairy cell leukaemia recurrent – Trials in Disease Marginal zone lymphoma refractory Sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regadenoson Pitavastatin Calcium Irinotecan Hydrochloride Fluciclovine (18F) ALG-000184 Brigatinib Glofitamab Pervi-Neo Follitropin Beta Edotreotide Wve-006 Tozorakimab R2R01 Berubicin Hydrochloride Ly3819469 Sodium Omx-0407 Rtx001 Procarbazine Hydrochloride Buclizine Hydrochloride Rct2100 More therapies…

    Learn about Your Condition

    Hepatic angiosarcoma Respiratory distress Uterine leiomyosarcoma Cognitive disorder Myotonia Hypereosinophilic syndrome Diabetes insipidus Radiation skin injury Ventricular extrasystoles Irritable bowel syndrome Vaginal infection Double hit lymphoma Intermittent claudication Lymphangiosarcoma Critical illness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Porphyria non-acute

  • Long-term study of bitopertin safety and effectiveness in patients with erythropoietic protoporphyria or X-linked protoporphyria

    Recruiting

    3 1 1
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria

    Not recruiting

    3 1
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dersimelagon Phosphate
    Bulgaria Czechia France Germany Italy The Netherlands +4

  • Study of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Porphyria non-acute
    Investigated Drugs:
    • Afamelanotide
    Belgium The Netherlands

  • Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

    Not recruiting

    3 1
    Investigated Drugs:
    • Dersimelagon Phosphate
    Bulgaria Czechia France Italy The Netherlands Poland +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!